Peptide user tore oesophagus after using counterfeit product, Australian regulator warns

AI Summary

TGA issues alert after person was hospitalised after believing they were taking experimental weight loss drug retatrutide Follow our Australia news live blog for latest updates Get our breaking news email, free app or daily news podcast A patient who tore their oesophagus after taking a counterfeit version of an experimental weight loss drug has prompted Australia’s medicines regulator to warn of serious risks of such products. Newsiline summarises this report from The Guardian Australia and links readers to the original publisher for the full story.

Key Points

• Original report published by The Guardian Australia.
• Newsiline stores only headline metadata, source credit, and a short summary.
• Readers are directed to the publisher for the complete article.

Why It Matters

This story may affect readers following the category, country, or source involved. Newsiline keeps the summary neutral and points to the publisher for full context.